Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Marathon
Manufacturing
EpiPen rival Kaléo snapped up in $310M deal
EpiPen rival Kaléo was acquired in a $310 million deal by Marathon Asset Management.
Joseph Keenan
Nov 30, 2021 9:35am
PTC scores expanded label for Emflaza in DMD
Jun 10, 2019 11:58am
Patient group urges BIO to boot Catalyst over $375K Firdapse price
Mar 7, 2019 10:20am
PTC in the hot seat again over price hikes on DMD med Emflaza
Jan 19, 2018 11:40am
It's time to force lower prices on Biogen MS drug: lawmaker
Sep 29, 2017 10:23am
FDA generics push hits Valeant price-hike poster child Isuprel
Aug 7, 2017 9:17am
